4//SEC Filing
Thorp Clay 4
Accession 0001415889-25-005325
CIK 0001539029other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:52 PM ET
Size
5.6 KB
Accession
0001415889-25-005325
Insider Transaction Report
Form 4
Thorp Clay
Director
Transactions
- Purchase
Common Stock
2025-02-24$0.92/sh+15,000$13,800→ 176,141 total
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.90 to $0.9321 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Includes an aggregate of 120,619 shares received as a pro rata distribution from Hatteras Venture Advisors III, LLC, Hatteras Venture Advisors IV SBIC, LLC, Hatteras Venture Advisors IV, LLC and Hatteras NC Fund, LP (the "Hatteras Entities"). In prior reports, the reporting person reported indirect beneficial ownership of 3,545,040 shares of the Issuer's common stock held by the Hatteras Entities.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001592380
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:52 PM ET
- Size
- 5.6 KB